Back to Resource Library
PURPOSE 1 Summary
![](https://www.prepwatch.org/wp-content/uploads/2024/08/PURPOSE-Summary.jpg)
This factsheet provides a summary of the PURPOSE 1 phase III clinical trial of lenacapavir for PrEP and F/TAF for cisgender women taking place in South Africa and Uganda.
This factsheet provides a summary of the PURPOSE 1 phase III clinical trial of lenacapavir for PrEP and F/TAF for cisgender women taking place in South Africa and Uganda.